HEADER MEMBRANE PROTEIN 08-OCT-23 8WP1 TITLE CRYO-EM STRUCTURE OF SUCR1 IN COMPLEX WITH CIS-EPOXYSUCCINIC ACID AND TITLE 2 GI PROTEINS COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUCCINATE RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I) SUBUNIT ALPHA-1; COMPND 7 CHAIN: C; COMPND 8 SYNONYM: ADENYLATE CYCLASE-INHIBITING G ALPHA PROTEIN; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(T) SUBUNIT COMPND 13 BETA-1; COMPND 14 CHAIN: D; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 4; COMPND 17 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(O) SUBUNIT COMPND 18 GAMMA-2; COMPND 19 CHAIN: E; COMPND 20 SYNONYM: G GAMMA-I; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SUCNR1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: GNAI1; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: GNB1; SOURCE 20 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 GENE: GNG2; SOURCE 27 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, SUCCINATE RECEPTOR, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR A.LIU,R.D.YE REVDAT 4 25-JUN-25 8WP1 1 REMARK REVDAT 3 13-NOV-24 8WP1 1 REMARK REVDAT 2 18-SEP-24 8WP1 1 JRNL REVDAT 1 11-SEP-24 8WP1 0 JRNL AUTH A.LIU,Y.LIU,W.ZHANG,R.D.YE JRNL TITL STRUCTURAL INSIGHTS INTO LIGAND RECOGNITION AND ACTIVATION JRNL TITL 2 OF THE SUCCINATE RECEPTOR SUCNR1. JRNL REF CELL REP V. 43 14381 2024 JRNL REFN ESSN 2211-1247 JRNL PMID 38923454 JRNL DOI 10.1016/J.CELREP.2024.114381 REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.150 REMARK 3 NUMBER OF PARTICLES : 202461 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8WP1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1300041671. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF SUCR1 IN REMARK 245 COMPLEX WITH CIS-EPOXYSUCCINIC REMARK 245 ACID AND GI PROTEINS REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5200.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY C 2 REMARK 465 HIS C 57 REMARK 465 GLU C 58 REMARK 465 ALA C 59 REMARK 465 GLY C 60 REMARK 465 TYR C 61 REMARK 465 SER C 62 REMARK 465 GLU C 63 REMARK 465 GLU C 64 REMARK 465 GLU C 65 REMARK 465 CYS C 66 REMARK 465 LYS C 67 REMARK 465 GLN C 68 REMARK 465 TYR C 69 REMARK 465 LYS C 70 REMARK 465 ALA C 71 REMARK 465 VAL C 72 REMARK 465 VAL C 73 REMARK 465 TYR C 74 REMARK 465 SER C 75 REMARK 465 ASN C 76 REMARK 465 THR C 77 REMARK 465 ILE C 78 REMARK 465 GLN C 79 REMARK 465 SER C 80 REMARK 465 ILE C 81 REMARK 465 ILE C 82 REMARK 465 ALA C 83 REMARK 465 ILE C 84 REMARK 465 ILE C 85 REMARK 465 ARG C 86 REMARK 465 ALA C 87 REMARK 465 MET C 88 REMARK 465 GLY C 89 REMARK 465 ARG C 90 REMARK 465 LEU C 91 REMARK 465 LYS C 92 REMARK 465 ILE C 93 REMARK 465 ASP C 94 REMARK 465 PHE C 95 REMARK 465 GLY C 96 REMARK 465 ASP C 97 REMARK 465 SER C 98 REMARK 465 ALA C 99 REMARK 465 ARG C 100 REMARK 465 ALA C 101 REMARK 465 ASP C 102 REMARK 465 ASP C 103 REMARK 465 ALA C 104 REMARK 465 ARG C 105 REMARK 465 GLN C 106 REMARK 465 LEU C 107 REMARK 465 PHE C 108 REMARK 465 VAL C 109 REMARK 465 LEU C 110 REMARK 465 ALA C 111 REMARK 465 GLY C 112 REMARK 465 ALA C 113 REMARK 465 ALA C 114 REMARK 465 GLU C 115 REMARK 465 GLU C 116 REMARK 465 GLY C 117 REMARK 465 PHE C 118 REMARK 465 MET C 119 REMARK 465 THR C 120 REMARK 465 ALA C 121 REMARK 465 GLU C 122 REMARK 465 LEU C 123 REMARK 465 ALA C 124 REMARK 465 GLY C 125 REMARK 465 VAL C 126 REMARK 465 ILE C 127 REMARK 465 LYS C 128 REMARK 465 ARG C 129 REMARK 465 LEU C 130 REMARK 465 TRP C 131 REMARK 465 LYS C 132 REMARK 465 ASP C 133 REMARK 465 SER C 134 REMARK 465 GLY C 135 REMARK 465 VAL C 136 REMARK 465 GLN C 137 REMARK 465 ALA C 138 REMARK 465 CYS C 139 REMARK 465 PHE C 140 REMARK 465 ASN C 141 REMARK 465 ARG C 142 REMARK 465 SER C 143 REMARK 465 ARG C 144 REMARK 465 GLU C 145 REMARK 465 TYR C 146 REMARK 465 GLN C 147 REMARK 465 LEU C 148 REMARK 465 ASN C 149 REMARK 465 ASP C 150 REMARK 465 SER C 151 REMARK 465 ALA C 152 REMARK 465 ALA C 153 REMARK 465 TYR C 154 REMARK 465 TYR C 155 REMARK 465 LEU C 156 REMARK 465 ASN C 157 REMARK 465 ASP C 158 REMARK 465 LEU C 159 REMARK 465 ASP C 160 REMARK 465 ARG C 161 REMARK 465 ILE C 162 REMARK 465 ALA C 163 REMARK 465 GLN C 164 REMARK 465 PRO C 165 REMARK 465 ASN C 166 REMARK 465 TYR C 167 REMARK 465 ILE C 168 REMARK 465 PRO C 169 REMARK 465 THR C 170 REMARK 465 GLN C 171 REMARK 465 GLN C 172 REMARK 465 ASP C 173 REMARK 465 VAL C 174 REMARK 465 LEU C 175 REMARK 465 ARG C 176 REMARK 465 THR C 177 REMARK 465 ARG C 178 REMARK 465 VAL C 179 REMARK 465 LYS C 180 REMARK 465 ARG D 129 REMARK 465 GLU D 130 REMARK 465 GLY D 131 REMARK 465 ASN D 132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE C 354 C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 83 -7.51 73.83 REMARK 500 LEU A 122 -6.65 74.86 REMARK 500 LYS A 264 -13.32 72.34 REMARK 500 GLN A 265 51.19 32.35 REMARK 500 GLN A 270 48.52 -79.89 REMARK 500 LYS C 46 -3.91 69.39 REMARK 500 PHE C 189 149.43 -172.29 REMARK 500 LYS C 192 -56.84 -120.84 REMARK 500 TRP C 258 -9.04 72.68 REMARK 500 ASP C 272 -9.22 80.76 REMARK 500 SER C 281 85.90 -157.45 REMARK 500 LEU D 30 49.03 -81.70 REMARK 500 MET D 61 147.49 -173.56 REMARK 500 THR D 86 -169.28 -117.50 REMARK 500 LYS D 127 -5.43 74.20 REMARK 500 THR D 164 36.71 71.64 REMARK 500 LYS D 280 -7.65 72.53 REMARK 500 ARG D 314 172.12 179.09 REMARK 500 SER E 31 -7.06 74.66 REMARK 500 SER E 57 -1.42 74.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-37707 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SUCR1 IN COMPLEX WITH CIS-EPOXYSUCCINIC ACID REMARK 900 AND GI PROTEINS DBREF 8WP1 A 9 312 UNP Q9BXA5 SUCR1_HUMAN 9 312 DBREF 8WP1 C 2 354 UNP P63096 GNAI1_HUMAN 2 354 DBREF 8WP1 D 3 340 UNP P62873 GBB1_HUMAN 3 340 DBREF 8WP1 E 8 63 UNP P59768 GBG2_HUMAN 8 63 SEQADV 8WP1 ALA C 203 UNP P63096 GLY 203 ENGINEERED MUTATION SEQADV 8WP1 SER C 326 UNP P63096 ALA 326 ENGINEERED MUTATION SEQRES 1 A 304 ALA THR CYS LYS ASN TRP LEU ALA ALA GLU ALA ALA LEU SEQRES 2 A 304 GLU LYS TYR TYR LEU SER ILE PHE TYR GLY ILE GLU PHE SEQRES 3 A 304 VAL VAL GLY VAL LEU GLY ASN THR ILE VAL VAL TYR GLY SEQRES 4 A 304 TYR ILE PHE SER LEU LYS ASN TRP ASN SER SER ASN ILE SEQRES 5 A 304 TYR LEU PHE ASN LEU SER VAL SER ASP LEU ALA PHE LEU SEQRES 6 A 304 CYS THR LEU PRO MET LEU ILE ARG SER TYR ALA ASN GLY SEQRES 7 A 304 ASN TRP ILE TYR GLY ASP VAL LEU CYS ILE SER ASN ARG SEQRES 8 A 304 TYR VAL LEU HIS ALA ASN LEU TYR THR SER ILE LEU PHE SEQRES 9 A 304 LEU THR PHE ILE SER ILE ASP ARG TYR LEU ILE ILE LYS SEQRES 10 A 304 TYR PRO PHE ARG GLU HIS LEU LEU GLN LYS LYS GLU PHE SEQRES 11 A 304 ALA ILE LEU ILE SER LEU ALA ILE TRP VAL LEU VAL THR SEQRES 12 A 304 LEU GLU LEU LEU PRO ILE LEU PRO LEU ILE ASN PRO VAL SEQRES 13 A 304 ILE THR ASP ASN GLY THR THR CYS ASN ASP PHE ALA SER SEQRES 14 A 304 SER GLY ASP PRO ASN TYR ASN LEU ILE TYR SER MET CYS SEQRES 15 A 304 LEU THR LEU LEU GLY PHE LEU ILE PRO LEU PHE VAL MET SEQRES 16 A 304 CYS PHE PHE TYR TYR LYS ILE ALA LEU PHE LEU LYS GLN SEQRES 17 A 304 ARG ASN ARG GLN VAL ALA THR ALA LEU PRO LEU GLU LYS SEQRES 18 A 304 PRO LEU ASN LEU VAL ILE MET ALA VAL VAL ILE PHE SER SEQRES 19 A 304 VAL LEU PHE THR PRO TYR HIS VAL MET ARG ASN VAL ARG SEQRES 20 A 304 ILE ALA SER ARG LEU GLY SER TRP LYS GLN TYR GLN CYS SEQRES 21 A 304 THR GLN VAL VAL ILE ASN SER PHE TYR ILE VAL THR ARG SEQRES 22 A 304 PRO LEU ALA PHE LEU ASN SER VAL ILE ASN PRO VAL PHE SEQRES 23 A 304 TYR PHE LEU LEU GLY ASP HIS PHE ARG ASP MET LEU MET SEQRES 24 A 304 ASN GLN LEU ARG HIS SEQRES 1 C 353 GLY CYS THR LEU SER ALA GLU ASP LYS ALA ALA VAL GLU SEQRES 2 C 353 ARG SER LYS MET ILE ASP ARG ASN LEU ARG GLU ASP GLY SEQRES 3 C 353 GLU LYS ALA ALA ARG GLU VAL LYS LEU LEU LEU LEU GLY SEQRES 4 C 353 ALA GLY GLU SER GLY LYS SER THR ILE VAL LYS GLN MET SEQRES 5 C 353 LYS ILE ILE HIS GLU ALA GLY TYR SER GLU GLU GLU CYS SEQRES 6 C 353 LYS GLN TYR LYS ALA VAL VAL TYR SER ASN THR ILE GLN SEQRES 7 C 353 SER ILE ILE ALA ILE ILE ARG ALA MET GLY ARG LEU LYS SEQRES 8 C 353 ILE ASP PHE GLY ASP SER ALA ARG ALA ASP ASP ALA ARG SEQRES 9 C 353 GLN LEU PHE VAL LEU ALA GLY ALA ALA GLU GLU GLY PHE SEQRES 10 C 353 MET THR ALA GLU LEU ALA GLY VAL ILE LYS ARG LEU TRP SEQRES 11 C 353 LYS ASP SER GLY VAL GLN ALA CYS PHE ASN ARG SER ARG SEQRES 12 C 353 GLU TYR GLN LEU ASN ASP SER ALA ALA TYR TYR LEU ASN SEQRES 13 C 353 ASP LEU ASP ARG ILE ALA GLN PRO ASN TYR ILE PRO THR SEQRES 14 C 353 GLN GLN ASP VAL LEU ARG THR ARG VAL LYS THR THR GLY SEQRES 15 C 353 ILE VAL GLU THR HIS PHE THR PHE LYS ASP LEU HIS PHE SEQRES 16 C 353 LYS MET PHE ASP VAL GLY ALA GLN ARG SER GLU ARG LYS SEQRES 17 C 353 LYS TRP ILE HIS CYS PHE GLU GLY VAL THR ALA ILE ILE SEQRES 18 C 353 PHE CYS VAL ALA LEU SER ASP TYR ASP LEU VAL LEU ALA SEQRES 19 C 353 GLU ASP GLU GLU MET ASN ARG MET HIS GLU SER MET LYS SEQRES 20 C 353 LEU PHE ASP SER ILE CYS ASN ASN LYS TRP PHE THR ASP SEQRES 21 C 353 THR SER ILE ILE LEU PHE LEU ASN LYS LYS ASP LEU PHE SEQRES 22 C 353 GLU GLU LYS ILE LYS LYS SER PRO LEU THR ILE CYS TYR SEQRES 23 C 353 PRO GLU TYR ALA GLY SER ASN THR TYR GLU GLU ALA ALA SEQRES 24 C 353 ALA TYR ILE GLN CYS GLN PHE GLU ASP LEU ASN LYS ARG SEQRES 25 C 353 LYS ASP THR LYS GLU ILE TYR THR HIS PHE THR CYS SER SEQRES 26 C 353 THR ASP THR LYS ASN VAL GLN PHE VAL PHE ASP ALA VAL SEQRES 27 C 353 THR ASP VAL ILE ILE LYS ASN ASN LEU LYS ASP CYS GLY SEQRES 28 C 353 LEU PHE SEQRES 1 D 338 GLU LEU ASP GLN LEU ARG GLN GLU ALA GLU GLN LEU LYS SEQRES 2 D 338 ASN GLN ILE ARG ASP ALA ARG LYS ALA CYS ALA ASP ALA SEQRES 3 D 338 THR LEU SER GLN ILE THR ASN ASN ILE ASP PRO VAL GLY SEQRES 4 D 338 ARG ILE GLN MET ARG THR ARG ARG THR LEU ARG GLY HIS SEQRES 5 D 338 LEU ALA LYS ILE TYR ALA MET HIS TRP GLY THR ASP SER SEQRES 6 D 338 ARG LEU LEU VAL SER ALA SER GLN ASP GLY LYS LEU ILE SEQRES 7 D 338 ILE TRP ASP SER TYR THR THR ASN LYS VAL HIS ALA ILE SEQRES 8 D 338 PRO LEU ARG SER SER TRP VAL MET THR CYS ALA TYR ALA SEQRES 9 D 338 PRO SER GLY ASN TYR VAL ALA CYS GLY GLY LEU ASP ASN SEQRES 10 D 338 ILE CYS SER ILE TYR ASN LEU LYS THR ARG GLU GLY ASN SEQRES 11 D 338 VAL ARG VAL SER ARG GLU LEU ALA GLY HIS THR GLY TYR SEQRES 12 D 338 LEU SER CYS CYS ARG PHE LEU ASP ASP ASN GLN ILE VAL SEQRES 13 D 338 THR SER SER GLY ASP THR THR CYS ALA LEU TRP ASP ILE SEQRES 14 D 338 GLU THR GLY GLN GLN THR THR THR PHE THR GLY HIS THR SEQRES 15 D 338 GLY ASP VAL MET SER LEU SER LEU ALA PRO ASP THR ARG SEQRES 16 D 338 LEU PHE VAL SER GLY ALA CYS ASP ALA SER ALA LYS LEU SEQRES 17 D 338 TRP ASP VAL ARG GLU GLY MET CYS ARG GLN THR PHE THR SEQRES 18 D 338 GLY HIS GLU SER ASP ILE ASN ALA ILE CYS PHE PHE PRO SEQRES 19 D 338 ASN GLY ASN ALA PHE ALA THR GLY SER ASP ASP ALA THR SEQRES 20 D 338 CYS ARG LEU PHE ASP LEU ARG ALA ASP GLN GLU LEU MET SEQRES 21 D 338 THR TYR SER HIS ASP ASN ILE ILE CYS GLY ILE THR SER SEQRES 22 D 338 VAL SER PHE SER LYS SER GLY ARG LEU LEU LEU ALA GLY SEQRES 23 D 338 TYR ASP ASP PHE ASN CYS ASN VAL TRP ASP ALA LEU LYS SEQRES 24 D 338 ALA ASP ARG ALA GLY VAL LEU ALA GLY HIS ASP ASN ARG SEQRES 25 D 338 VAL SER CYS LEU GLY VAL THR ASP ASP GLY MET ALA VAL SEQRES 26 D 338 ALA THR GLY SER TRP ASP SER PHE LEU LYS ILE TRP ASN SEQRES 1 E 56 SER ILE ALA GLN ALA ARG LYS LEU VAL GLU GLN LEU LYS SEQRES 2 E 56 MET GLU ALA ASN ILE ASP ARG ILE LYS VAL SER LYS ALA SEQRES 3 E 56 ALA ALA ASP LEU MET ALA TYR CYS GLU ALA HIS ALA LYS SEQRES 4 E 56 GLU ASP PRO LEU LEU THR PRO VAL PRO ALA SER GLU ASN SEQRES 5 E 56 PRO PHE ARG GLU HET U9S A 401 11 HETNAM U9S (2R,3S)-OXIRANE-2,3-DICARBOXYLIC ACID HETSYN U9S CIS-2,3-EPOXYSUCCINIC ACID FORMUL 5 U9S C4 H4 O5 FORMUL 6 HOH *(H2 O) HELIX 1 AA1 CYS A 11 TYR A 24 1 14 HELIX 2 AA2 TYR A 24 PHE A 50 1 27 HELIX 3 AA3 ASN A 56 THR A 75 1 20 HELIX 4 AA4 LEU A 76 SER A 82 1 7 HELIX 5 AA5 GLY A 91 TYR A 121 1 31 HELIX 6 AA6 HIS A 131 GLN A 134 5 4 HELIX 7 AA7 LYS A 135 LEU A 155 1 21 HELIX 8 AA8 ILE A 157 ASN A 162 1 6 HELIX 9 AA9 ASP A 174 SER A 178 5 5 HELIX 10 AB1 ASP A 180 PHE A 196 1 17 HELIX 11 AB2 PHE A 196 ARG A 219 1 24 HELIX 12 AB3 GLU A 228 ARG A 259 1 32 HELIX 13 AB4 VAL A 271 PHE A 285 1 15 HELIX 14 AB5 PHE A 285 LEU A 297 1 13 HELIX 15 AB6 GLY A 299 ARG A 311 1 13 HELIX 16 AB7 SER C 6 ALA C 31 1 26 HELIX 17 AB8 SER C 47 MET C 53 1 7 HELIX 18 AB9 GLU C 207 GLU C 216 5 10 HELIX 19 AC1 ASN C 241 ASN C 255 1 15 HELIX 20 AC2 LEU C 273 LYS C 279 1 7 HELIX 21 AC3 PRO C 282 CYS C 286 5 5 HELIX 22 AC4 THR C 295 ASP C 309 1 15 HELIX 23 AC5 LYS C 330 CYS C 351 1 22 HELIX 24 AC6 LEU D 4 ALA D 24 1 21 HELIX 25 AC7 GLN D 32 ASN D 36 5 5 HELIX 26 AC8 ALA E 10 ALA E 23 1 14 HELIX 27 AC9 ALA E 33 HIS E 44 1 12 SHEET 1 AA1 2 VAL A 164 THR A 166 0 SHEET 2 AA1 2 GLY A 169 THR A 171 -1 O GLY A 169 N THR A 166 SHEET 1 AA2 6 VAL C 185 THR C 190 0 SHEET 2 AA2 6 HIS C 195 ASP C 200 -1 O PHE C 196 N PHE C 189 SHEET 3 AA2 6 GLU C 33 GLY C 40 1 N VAL C 34 O LYS C 197 SHEET 4 AA2 6 ALA C 220 ALA C 226 1 O ILE C 222 N LEU C 39 SHEET 5 AA2 6 SER C 263 ASN C 269 1 O PHE C 267 N PHE C 223 SHEET 6 AA2 6 ILE C 319 HIS C 322 1 O TYR C 320 N LEU C 266 SHEET 1 AA3 4 THR D 47 LEU D 51 0 SHEET 2 AA3 4 LEU D 336 TRP D 339 -1 O LEU D 336 N LEU D 51 SHEET 3 AA3 4 VAL D 327 GLY D 330 -1 N THR D 329 O LYS D 337 SHEET 4 AA3 4 CYS D 317 VAL D 320 -1 N GLY D 319 O ALA D 328 SHEET 1 AA4 4 ILE D 58 HIS D 62 0 SHEET 2 AA4 4 VAL D 71 SER D 74 -1 O ALA D 73 N TYR D 59 SHEET 3 AA4 4 LYS D 78 TRP D 82 -1 O ILE D 80 N SER D 72 SHEET 4 AA4 4 LYS D 89 PRO D 94 -1 O ILE D 93 N LEU D 79 SHEET 1 AA5 4 VAL D 100 TYR D 105 0 SHEET 2 AA5 4 TYR D 111 GLY D 116 -1 O GLY D 115 N MET D 101 SHEET 3 AA5 4 CYS D 121 ASN D 125 -1 O SER D 122 N CYS D 114 SHEET 4 AA5 4 ARG D 134 LEU D 139 -1 O LEU D 139 N CYS D 121 SHEET 1 AA6 4 LEU D 146 PHE D 151 0 SHEET 2 AA6 4 ILE D 157 SER D 161 -1 O SER D 160 N SER D 147 SHEET 3 AA6 4 THR D 165 TRP D 169 -1 O TRP D 169 N ILE D 157 SHEET 4 AA6 4 GLN D 176 THR D 181 -1 O PHE D 180 N CYS D 166 SHEET 1 AA7 4 VAL D 187 LEU D 192 0 SHEET 2 AA7 4 LEU D 198 ALA D 203 -1 O GLY D 202 N MET D 188 SHEET 3 AA7 4 SER D 207 ASP D 212 -1 O TRP D 211 N PHE D 199 SHEET 4 AA7 4 CYS D 218 THR D 223 -1 O ARG D 219 N LEU D 210 SHEET 1 AA8 4 ILE D 229 PHE D 234 0 SHEET 2 AA8 4 ALA D 240 SER D 245 -1 O ALA D 242 N CYS D 233 SHEET 3 AA8 4 CYS D 250 ASP D 254 -1 O PHE D 253 N PHE D 241 SHEET 4 AA8 4 GLN D 259 TYR D 264 -1 O TYR D 264 N CYS D 250 SHEET 1 AA9 4 ILE D 273 PHE D 278 0 SHEET 2 AA9 4 LEU D 284 TYR D 289 -1 O LEU D 286 N SER D 277 SHEET 3 AA9 4 CYS D 294 ASP D 298 -1 O TRP D 297 N LEU D 285 SHEET 4 AA9 4 ARG D 304 LEU D 308 -1 O LEU D 308 N CYS D 294 SSBOND 1 CYS A 11 CYS A 268 1555 1555 2.03 SSBOND 2 CYS A 95 CYS A 172 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 18 2111 CONECT 694 1327 CONECT 1327 694 CONECT 2111 18 CONECT 7321 7322 7325 7326 CONECT 7322 7321 7323 7329 7330 CONECT 7323 7322 7324 7329 7331 CONECT 7324 7323 7327 7328 CONECT 7325 7321 CONECT 7326 7321 CONECT 7327 7324 CONECT 7328 7324 CONECT 7329 7322 7323 CONECT 7330 7322 CONECT 7331 7323 MASTER 283 0 1 27 36 0 0 6 7326 4 15 83 END